性激素影响ORMDL3表达:对性相关喘表型的影响
Elisabetta Granato1, Ida Cerqua2, Antonietta Rossi2
1Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.
The Journal of allergy and clinical immunology
|December 8, 2025
概括
这项研究表明,受雌激素影响的ORMDL3基因在喘中性别差异中起着关键作用. 准ORMDL3-sphingosine-1-phosphate通路可以帮助在喘模型中使呼吸道功能正常化.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 喘在患病率和严重程度上表现出显著的性别差异,其潜在的分子机制尚不清楚.
- 脂代谢的遗传变异,特别是ORMDL3基因,与喘风险有关.
研究的目的:
- 研究ORMDL3在气道功能和喘类症状的性别差异中的作用.
- 探索雌激素和过敏原对ORMDL3表达和相关途径的影响.
主要方法:
- 在暴露于雌激素和过敏原的人类肺组织和支气管细胞中测量ORMDL3表达.
- 利用小鼠喘模型评估ORMDL3,呼吸道响应和重塑的性别依赖差异.
- 采用了雌激素和ORMDL3-sphingosine-1-phosphate (S1P) 轴的药理学调制.
主要成果:
- 女性肺部表现出更高的ORMDL3表达,与肺功能相关.
- 雌激素上调ORMDL3和改变了气道细胞中的脂代谢.
- 对过敏原的暴露放大了ORMDL3表达和呼吸道炎症,特别是在女性身上.
- 在体内,雌性小鼠表现出增加的ORMDL3,S1P,气道过敏反应和重塑,这些都被雌激素或他莫西芬部分逆转.
- 抑制ORMDL3-S1P轴在雌性小鼠中特别减弱了喘特征.
结论:
- ORMDL3是一种对雌激素敏感的基因,影响了呼吸道的反应.
- 通过ORMDL3调节脂代谢,有助于喘中的性别差异.
- 雌激素信号传递和ORMDL3通路为性别特异性喘管理提供了潜在的治疗点.
相关概念视频
Background and Environment Affect Phenotype
7.4K
Although the genetic makeup of an organism plays a major role in determining the phenotype, there are also several environmental factors, such as temperature, oxygen availability, presence of mutagens, that can alter an organism’s phenotype.
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
7.4K
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K


